Bar graphs of mean beta values for hard and easy trials www.selleckchem.com/products/Bosutinib.html versus baseline (Fig. ​(Fig.8)8)

suggested that both HC and SZ had greater activation to the easy trials than to the hard trials in the region, with SZ exhibiting a greater difference between easy and hard trials. Figure 8 Mean (± standard error) parameters estimates extracted from the each participant’s contrast maps for hard trials and easy trials using a Inhibitors,research,lifescience,medical functionally defined composite mask for the between-group www.selleckchem.com/products/Trichostatin-A.html results for hard versus easy trials. HC, healthy … Inconsistent SZ In a within-group analysis (Table S5), limited activation in inconsistent patients during DD task versus SMC trials occurred in a small region in the left frontal cortex and in regions in the left parietal and occipital cortices. Table ​Table44 shows the between-group comparisons of activation to DD task>SMC trials in inconsistent patients versus consistent controls and in inconsistent patients versus Inhibitors,research,lifescience,medical consistent patients. The inconsistent patients exhibited greater activation to the task than controls. The greater activation was in two clusters within posterior medial wall regions, such as the precuneus, posterior, and middle cingulate, and calcarine cortex (Fig. ​(Fig.9,9, left). To clarify the group difference, we extracted mean parameter estimates from these

clusters. Results were similar in both clusters Inhibitors,research,lifescience,medical – there was significantly decreased activation in the consistent controls and marginally significant increased activation in inconsistent patients. Results for one of the clusters are plotted in Figure ​Figure9,9, right. Table 4 Between-group results for activation to Inhibitors,research,lifescience,medical task>SMC trials1 Figure 9 Between-group

fMRI results for activation in inconsistent patients (n = 9) when compared with consistent controls (n = 14) to task>SMC trials for the largest, medial cluster activated. Left, the sagittal brain section shows greater activation … For the DD task>SMC trial comparison Inhibitors,research,lifescience,medical of the two SZ groups, inconsistent patients showed greater activation than consistent patients in more frontal areas, such Dacomitinib as the left superior and middle frontal gyri, and more medially, in the superior medial frontal gyrus and region of the pre-SMA (Strick et al. 1998; Zhang et al. 2012) (Table ​(Table4;4; Fig. ​Fig.10,10, left). Comparison of mean parameter estimates for this cluster (Fig. ​(Fig.10,10, right) showed activation in the inconsistent patients and marginally significant deactivation in consistent SZ. The opposite contrast of activation to task trials>SMC trials in consistent patients greater than the inconsistent patients was not significant. Figure 10 Left, the brain section shows between-group fMRI results for activation to task>SMC trials. More activation occurred in inconsistent SZ (n = 9) when compared with consistent SZ (n = 14) in the supplementary motor area, superior frontal, and superior …